GlassScriptPhysician profile
Abigail Lowe
NPI 1073140752
$2,494.38
in general payments reported to CMS, 2019-2025
24 companies · $510 in 2025
The $510 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $658 · 2022: $896 · 2023: $317 · 2024: $114 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917 · Education: $23.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.80 |
| Education | $23.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $672.20 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $250.56 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $233.42 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $195.02 | 2021-2025 | Jascayd, Jardiance |
| Janssen Pharmaceuticals, INC | $140.63 | 2021-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $110.74 | 2021-2023 | Eliquis |
| Abbott Laboratories | $110.44 | 2021-2024 | Xience Skypoint |
| Merck Sharp & Dohme LLC | $109.74 | 2021-2023 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $88.40 | 2025 | Dupixent |
| Janssen Scientific Affairs, LLC | $76.25 | 2025 | Tecvayli, Carvykti |
| Amgen INC. | $75.66 | 2021-2022 | |
| Viatris Specialty LLC | $56.44 | 2025 | Yupelri |
| Medtronic, INC. | $56.22 | 2021-2022 | |
| Esperion Therapeutics, INC. | $49.06 | 2021-2022 | |
| Genzyme Corporation | $43.43 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $43.39 | 2023-2025 | |
| Pfizer INC. | $34.38 | 2022-2023 | |
| Avadel Cns Pharmaceuticals, LLC | $26.26 | 2025 | Lumryz |
| Baxter Healthcare | $24.34 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Grifols USA, LLC | $23.31 | 2025 | Prolastin-C Liquid |
| Philips North America LLC | $20.72 | 2025 | Vest Therapy Und |
| Lilly USA, LLC | $20.12 | 2025 | Zepbound |
| Novo Nordisk INC | $19.41 | 2024 | Ozempic |
| Caris Mpi, INC. | $14.24 | 2025 | Mi Cancer Seek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.